Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
| Fiscal year / year | Dermira revenue |
|---|---|
| 2020 | $44.5M |
| 2021 | $63.1M |
| 2022 | $73.7M |
| 2023 | $79.2M |
Rate Dermira's financial transparency
| Year | Dermira growth |
|---|---|
| 2021 | 42%↑ |
| 2022 | 17%↑ |
| 2023 | 7%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | - | $19.6M | $17.5M |
| 2022 | $23.3M | $18.3M | $16.1M | $16.0M |
| 2023 | $12.2M | $17.2M | $34.5M | $15.3M |
| 2024 | $13.0M | $14.9M | - | - |
Do you work at Dermira?
Did Dermira meet its revenue projections?
| CEO | Thomas G. Wiggans |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 333 |
| Date Founded | 2010 |
| Headquarters | Menlo Park, California |
| Number of Locations | 1 |
| Revenue | $79.2M |
| Gross Proft | $52.5M (2023) |
| PE Ratio | -303.66 |
| Tax Rate | -0.1% |
| Market Capitalization | $1.2B |
| Ticker | DERM |
Dermira received early financing of $42.0M on 2011-10-20.
| Series | Round size | Date |
|---|---|---|
| Series A | $42M | 10/2011 |
| Series B | $35M | 06/2013 |
| Series C | $51M | 08/2014 |
| Post Ipo Equity | $1.5M | 09/2016 |
| Post Ipo Equity | $193.8M | 03/2017 |
| Post Ipo Equity | $500K | 12/2017 |
| Post Ipo Debt | $125M | 12/2018 |
| Post Ipo Equity | $1M | 12/2018 |
| Post Ipo Equity | $149.5M | 03/2019 |
| Investors | Security type |
|---|---|
| Bay City Capital | Series A |
| Canaan Partners | Series A |
| New Enterprise Associates (NEA) | Series A |
| Bay City Capital | Series B |
| Canaan Partners | Series B |
| New Enterprise Associates (NEA) | Series B |
| MARUHO CO LTD | Series B |
| Bay City Capital | Series C |
| Canaan Partners | Series C |
| Apple Tree Partners | Series C |
| New Enterprise Associates (NEA) | Series C |
| UCB | Series C |
| Sabby Capital | Series C |
| Rock Springs Capital | Series C |
| Aisling Capital | Series C |
| Athyrium Capital Management LP | Post Ipo Debt |
Zippia gives an in-depth look into the details of Dermira, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dermira. The employee data is based on information from people who have self-reported their past or current employments at Dermira. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dermira. The data presented on this page does not represent the view of Dermira and its employees or that of Zippia.
Dermira may also be known as or be related to DERMIRA INC., Dermira, Dermira Inc and Dermira, Inc.